Johnson & Johnson (NYSE:JNJ)
| 163.62 Delayed Data As of 4:00pm ET |  +0.22 / +0.13%Today’s Change | 155.72 Today|||52-Week Range 186.69 | -7.38% Year-to-Date |
Latest JNJ News | Press Releases
| Top 5 4th Quarter Trades of Swiss National Bank 11:00am / GuruFocus News - Paid Partner Content | 3 Dividend Stocks That Will Hold Up No Matter the Market Conditions 5:30am / MotleyFool.com - Paid Partner Content |
| A Look at Pharma ETFs Post Q4 Earnings 10:05am / Zacks.com - Paid Partner Content | Will AbbVie's (ABBV) New Drugs Continue to Drive Q4 Earnings? Feb 07 / Zacks.com - Paid Partner Content |
| Top 5 4th Quarter Trades of OPPENHEIMER & CO INC 9:00am / GuruFocus News - Paid Partner Content | Catalent (CTLT) Surges on Rumors of Acquisition by Danaher Feb 07 / Zacks.com - Paid Partner Content |
| Sivik Global Healthcare LLC Buys 3, Sells 2 in 4th Quarter 9:00am / GuruFocus News - Paid Partner Content | Top 5 4th Quarter Trades of Savant Capital, LLC Feb 07 / GuruFocus News - Paid Partner Content |
| This Could Cost Johnson & Johnson Billions in Profit 8:20am / MotleyFool.com - Paid Partner Content | Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now? Feb 07 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 163.40 |
| Today’s open | 163.30 |
| Day’s range | 162.89 - 164.56 |
| Volume | 6,054,627 |
| Average volume (3 months) | 6,948,012 |
| Market cap | $432.8B |
Data as of 4:00pm ET, 02/08/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +3.57% |
| Earnings growth (next 5 years) | +4.29% |
| Revenue growth (last year) | +1.26% |
| P/E ratio | 22.8 |
| Price/Sales | 4.96 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | +1.10 | +0.32% |
| MRKMerck | +0.97 | +0.92% |
| ABBVAbbVie | -0.55 | -0.38% |
| PFEPfizer | +0.38 | +0.87% |
Data as of 4:00pm ET, 02/08/2023
Financials
| Next reporting date | April 18, 2023 |
| EPS forecast (this quarter) | $2.52 |
| Annual revenue (last year) | $94.9B |
| Annual profit (last year) | $17.9B |
| Net profit margin | 18.90% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
